Nobel medicine prize goes to 3 scientists for research into brain activity

STOCKHOLM — The Nobel Prize in medicine was awarded Monday to three scientists working on the mechanisms the brain uses to switch on, or off, the activity of individual nerve cells.

Karl Deisseroth, 54, Peter Hegemann, 71, and Georg Nagel, 73, have carried out research into light-gated ion channels and optogenetics.

The Nobel Assembly lauded their work, writing on X that the method “is now being used in laboratories around the world to reveal the brain's mysteries”.

The assembly said Deisseroth is based at Stanford University in California, while Hegemann is at Humboldt University in Berlin and Nagel at the University of Wurzburg, also in Germany.

Optogenetics opened what the Nobel assembly called a new era in neuroscience, the discovery of a light-controlled switch to turn on and off nerve cells and circuits in the brain to better learn how it works — to start unravelling the pathways that lead to behaviour and disease.

It started when Hegemann explored how a single-celled type of green algae can swim toward light. He and Nagel discovered a particular protein that, when illuminated by blue light, opens a channel to create an electrical impulse. Putting that protein into other cells makes them light-sensitive.

Deisseroth then worked with the gene that controls that protein to create a light-controlled switch for nerve cells in the brains of living mice.

Deisseroth, a self-described night owl, said he was up late in his Northern California home working on papers and emailing his students. He had just gone to lie down when he got the call from the Nobel assembly.

“No real sleep was achieved,” he told The Associated Press in a phone call an hour after the announcement.

He said the next task on his to-do list was to pack school lunches for his children, who were still sound asleep.

“That's my one obligation I have in the next few hours, to make sure I make their sandwiches,” he said.